1.
Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium
2.
Enhancing the value of the sFlt-1/PlGF ratio for the prediction of preeclampsia: Cost analysis from the Belgian healthcare payers’ perspective
3.
4.
Screening for pregestational and gestational diabetes in pregnancy: a survey of obstetrical centers in the northern part of Belgium